Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/GSK-PLC-9590199/noticia/La-NMPA-aprueba-el-esquema-de-dos-dosis-de-la-vacuna-contra-el-VPH-Cervarix-de-GSK-plc-40570458/?utm_source=whatsapp&utm_medium=social&utm_campaign=share